Literature DB >> 18653464

Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus.

Zachary D Nightingale1, Chinmay Patkar, Alan L Rothman.   

Abstract

Dengue virus (DENV), a re-emerging arbovirus, readily infects dendritic cells (DC) in culture and in vivo. However, there have been contradictory reports regarding the effect of DENV infection on DC activation and maturation. DC undergo a series of functional changes following exposure to infectious agents, including cytokine production and costimulatory and MHC molecule induction, culminating in stimulation of adaptive immune responses. Immunological memory to primary DENV infection critically influences disease severity during subsequent infections with heterologous serotypes. To explore these phenomena, we examined DENV infection-dependent and -independent effects on DC secretory, phenotypic, and allostimulatory functions. DENV infection of DC resulted in the secretion of a broad array of cytokines and chemokines. Type I IFN produced by DC inhibited propagation of infection and induced the chemokine IFN-gamma-inducible protein 10 (IP-10; CXCL10). Based on intracellular cytokine staining, infected DC produced less IP-10 but more TNF-alpha than uninfected bystander cells in the same culture. DENV exposure activated surface molecule expression on infected and bystander cells; infected DC had enhanced programmed death ligand 2 (PD-L2) and MHC II expression but reduced levels of PD-L1, CD80, CD86, and MHC I relative to bystander DC. Dengue-infected DC cultures stimulated resting allogeneic CD4 T cell proliferation, although an increasing multiplicity of infection was associated with decreasing stimulatory capacity of DC. These data demonstrate that functional maturation of DC in response to dengue infection is modified by the presence of virus through IFN-dependent and -independent mechanisms with consequences for the development of adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653464      PMCID: PMC2538589          DOI: 10.1189/jlb.0208105

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  59 in total

1.  Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies.

Authors:  D M Morens; S B Halstead
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

2.  Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study.

Authors:  M G Guzmán; G P Kouri; J Bravo; M Soler; S Vazquez; L Morier
Journal:  Am J Trop Med Hyg       Date:  1990-02       Impact factor: 2.345

3.  Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.

Authors:  M S Diamond; E Harris
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

4.  Activation-induced expression of human programmed death-1 gene in T-lymphocytes.

Authors:  R Vibhakar; G Juan; F Traganos; Z Darzynkiewicz; L R Finger
Journal:  Exp Cell Res       Date:  1997-04-10       Impact factor: 3.905

Review 5.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function.

Authors:  B Canque; M Rosenzwajg; S Camus; M Yagello; M L Bonnet; M Guigon; J C Gluckman
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

7.  Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.

Authors:  Bettina Schreiner; Meike Mitsdoerffer; Bernd C Kieseier; Lieping Chen; Hans-Peter Hartung; Michael Weller; Heinz Wiendl
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

8.  Induction of apoptosis in mature T cells by tumour necrosis factor.

Authors:  L Zheng; G Fisher; R E Miller; J Peschon; D H Lynch; M J Lenardo
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

9.  Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors.

Authors:  A Granelli-Piperno; B Moser; M Pope; D Chen; Y Wei; F Isdell; U O'Doherty; W Paxton; R Koup; S Mojsov; N Bhardwaj; I Clark-Lewis; M Baggiolini; R M Steinman
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  32 in total

1.  Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study.

Authors:  Jeremy Seto; Liang Qiao; Carolin A Guenzel; Sa Xiao; Megan L Shaw; Fernand Hayot; Stuart C Sealfon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Decreased peripheral dendritic cell numbers in dengue virus infection.

Authors:  Marcelo De Carvalho Bittencourt; Jenny Martial; André Cabié; Laurent Thomas; Raymond Césaire
Journal:  J Clin Immunol       Date:  2011-10-04       Impact factor: 8.317

3.  Interplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.

Authors:  María F Pascutti; Ana M Rodríguez; Juliana Falivene; Luis Giavedoni; Ingo Drexler; M Magdalena Gherardi
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

4.  Oligomeric procyanidins stimulate innate antiviral immunity in dengue virus infected human PBMCs.

Authors:  Emily M Kimmel; Maria Jerome; Jeff Holderness; Deann Snyder; Sharon Kemoli; Mark A Jutila; Jodi F Hedges
Journal:  Antiviral Res       Date:  2011-03-01       Impact factor: 5.970

5.  Dermal CD14(+) Dendritic Cell and Macrophage Infection by Dengue Virus Is Stimulated by Interleukin-4.

Authors:  Evelyne Schaeffer; Vincent Flacher; Vasiliki Papageorgiou; Marion Decossas; Jean-Daniel Fauny; Melanie Krämer; Christopher G Mueller
Journal:  J Invest Dermatol       Date:  2014-12-18       Impact factor: 8.551

6.  A plasmid-based reporter system for live cell imaging of dengue virus infected cells.

Authors:  Carey L Medin; Sierra Valois; Chinmay G Patkar; Alan L Rothman
Journal:  J Virol Methods       Date:  2014-10-28       Impact factor: 2.014

7.  High-dimensional CyTOF analysis of dengue virus-infected human DCs reveals distinct viral signatures.

Authors:  Rebecca E Hamlin; Adeeb Rahman; Theodore R Pak; Kevin Maringer; Ignacio Mena; Dabeiba Bernal-Rubio; Uma Potla; Ana M Maestre; Anthony C Fredericks; El-Ad D Amir; Andrew Kasarskis; Irene Ramos; Miriam Merad; Ana Fernandez-Sesma
Journal:  JCI Insight       Date:  2017-07-06

8.  Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.

Authors:  Shelly J Robertson; Kirk J Lubick; Brett A Freedman; Aaron B Carmody; Sonja M Best
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

9.  Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response.

Authors:  G F Silveira; D M Strottmann; L de Borba; D S Mansur; N I T Zanchin; J Bordignon; C N Duarte dos Santos
Journal:  Clin Exp Immunol       Date:  2015-10-18       Impact factor: 4.330

10.  Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.

Authors:  Elizabeth Townsley; Marcia Woda; Stephen J Thomas; Siripen Kalayanarooj; Robert V Gibbons; Ananda Nisalak; Anon Srikiatkhachorn; Sharone Green; Henry A F Stephens; Alan L Rothman; Anuja Mathew
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.